A Pilot/Phase I Study of Panobinostat (LBH589) in Patients With Metastatic Melanoma.
Phase of Trial: Phase I
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Panobinostat (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 27 Mar 2017 Status changed from active, no longer recruiting to completed.
- 15 Feb 2017 Planned End Date changed from 1 Jan 2017 to 1 Mar 2017.
- 04 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Jan 2017.